NEW YORK (GenomeWeb) – Agilent Technologies today said it named Alacris Theranostics an Agilent Certified Service Provider for target enrichment.
Alacris is based in Berlin and provides molecular analysis and bioinformatics through an approach called ModCell, which is intended to match patients with appropriate therapies. According to Agilent, Alacris exploits next-generation sequencing and other omics data to facilitate drug development and personalized medicine in cancer and other complex diseases.
ModCell was developed at the Max Planck Institute for Molecular Genetics and is exclusively licensed to Alacris.
For its CSP program, Agilent chooses companies that will leverage Agilent's technologies in providing analysis services. Agilent trains the firms on its workflow to ensure that customers receive consistent data quality, reproducibility, and reliability, it said.